Share Prices & Company Research

Market News

22 Feb 2021 | 08:43

Dechra Pharmaceuticals' interim revenues and profits improve

(Sharecast News) - Drugmaker Dechra Pharmaceuticals said on Monday that reported group revenues and operating profits had both increased throughout the six months ended 31 December.

Reported interim group revenues were up 21.8% at a constant exchange rate, while reported operating profits increased by 74.2% as a result of the company's strong trading performance.

Underlying operating profits were 32.7% higher as operating margins improving by 240 basis points to 27.0%.

European pharmaceutical revenues grew 21.7%, while across the pond, North American pharmaceuticals income improved 21.9% year-on-year.

Dechra also reported underlying diluted earnings per share growth of 24.7% to 54.28 pence and increased its interim dividend by 8.0% to 11.11p per share.

Chief executive Ian Page said: "Despite 2020 being one of the most challenging years in Dechra's history, it is pleasing to report that the calendar year ended strongly resulting in an excellent performance in the first half of our financial year."

As of 0840 GMT, Dechra shares were down 2.17% at 3,533.52p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.